Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2026 ,inter alia, to consider and approve the audited results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jenburkt Pharmaceuticals Ltd has informed BSE that a board meeting is scheduled for May 5, 2026 at the company's registered office. The meeting will take on record the audited financial results for the quarter and financial year ended March 31, 2026. Additionally, the board will consider recommending a dividend, if any. This is a standard intimation under SEBI Listing Regulations and does not contain any actual financial figures or results.
This is a routine pre-results announcement intimation. Shareholders should await the actual results disclosure for any financial performance details. The dividend consideration is positive but speculative until results are approved.